Articles On Telix Pharmaceuticals (ASX:TLX)

It's been another horrid day for the S&P/ASX 200 Index (ASX: XJO) in a selloff trend that seems to be accelerating this week. Today's falls are the third day of drops in a row for the ASX 200 after...

Local shares slumped by more than 1.1pc today All 11 sectors were down, led by BHP and Allkem Phil Lowe made his final speech as RBA governor   The ASX slipped further on Thursday, down by -1.2% as the index tracked its worst day in three...

The S&P/ASX 200 Index (ASX: XJO) seems to be starting a run of bad news for ASX investors. After yesterday’s mild fall, the ASX 200 took a deeper dive into negative territory today. By close of tradi...

MELBOURNE, Australia, Sept. 6, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations featuring the Company’s theranostic programs at the 36th Annual Congress of the European Associ...

In this week's Weekly Insights:-Outlook Negative, With Plenty Of Silver Linings-Conviction Calls & Best IdeasBy Rudi Filapek-Vandyck, EditorOne of the stand-out features of the August results season has been the resilience of household ...

Damian Cottier dives into why and how ASX investors can use ESG principles to their advantage, and offers up three examples in Telix Pharmaceuticals (ASX: TLX), Alpha HPA Ltd (ASX: A4n) and Calix Ltd (ASX: CXL). Now more than ever we need t...

Welcome to the FNArena Corporate Results Monitor. Today's Reports: ((ALG)) - Ardent Leisure ((ABB)) - Aussie Broadband ((AFG)) - Australian Finance Group ((AVG)) - Australian Vintage ((BVS)) - Bravura Solutions ((CBO)) - Cobram Estate Oli...

Do you have $20,000 saved that you could invest in ASX shares? If so, I reckon you could turn it into a portfolio that pays you an extra income of $15,000 each year. It’s like having a second job, but without the work. Let’s take a look at...

The S&P/ASX 200 Index (ASX: XJO) has ended its three-day winning streak with a disappointing finish to the trading week today. At the conclusion of today’s session, the ASX 200 had recorded a notable drop...

In afternoon trade, the S&P/ASX 200 Index (ASX: XJO) is on course to record another gain. At the time of writing, the benchmark index is up 0.45% to 7,181.6 points. Four ASX shares that are rising more than most today are listed belo...

These four ASX healthcare shares are bucking the trend today with strong share price gains following the release of their latest financial reports. As earnings season continues, the S&P/ASX 200 Health Care Index (ASX: XHJ) is down 0.0...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price is having a strong session. At the time of writing, the ASX 200 healthcare stock is up almost 12% to $10.94. This follows the release of the company’s half-year results. Telix share pr...

Telix (ASX:TLX) has reported total revenue of $220.8 million for the six months to the end of June 2023, driven by growth in prostate cancer imagined agent Illuccix.

MELBOURNE, Australia, Aug. 23, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces its financial results for the half-year ended 30 June 2023. All figures are in AUD$ unless otherwise stated.[...

Buying any S&P/ASX 200 Index (ASX: XJO) stock undoubtedly comes with risks. But if you pick the right one and hold it for a long time, extraordinary riches can come about. Even though the Australian bourse is famous for its dividend st...

MELBOURNE, Australia, Aug. 11, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in China in the pivotal Phase III registration study of TLX591-CDx (Illuc...

Telix Pharmaceuticals (TLX) doses its first Chinese patient in the phase III study of TLX591-CDx (Illuccix) with Grand Pharmaceutical Group Illuccix is employed for positron emission tomography (PET) imaging of prostate cancer The Chi...

MELBOURNE, Australia, Aug. 8, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that a first patient has been dosed in a Phase I study of the Company’s investigational therapy TLX101 (4-L-[1...

How do you spot multibagger stocks? Which sectors can you find them in, and which ASX stocks have good potential? Stockhead reached out to VP Capital’s co-founder, John So   As the name suggests, multibaggers are stocks that can generate...

China’s export controls on gallium and germanium come into effect today with licensing procedures with provincial governments now required to export them freely. Both metals are critical components in semiconductor chips, the building block...

Oncology radiology leader Telix Pharmaceuticals is taking on the US, Tim Boreham reports. By Tim Boreham ASX Code: ((TLX)) Share price: $11.26 Shares on issue: 318,808,268 Market cap: $3.58 billion Chief executive officer: Dr Christian Behr...

Australian Eagle Asset Management is the top performing fund manager over a five-year period with their Equity Strategy Fund delivering an impressive return of 11.6 per cent per annum, compared to the ASX 100 Accumulation Index which return...

In this week's Weekly Insights:-Opportunities With A Five Year Horizon-Company Reports: Early Trends-Company Reports: Inflation-Company Reports: Conviction-Company Reports: Technology Sector-REITs In FocusBy Rudi Filapek-Vandyck, Editor FNA...

The S&P/ASX 200 Index (ASX: XJO) has suffered a disappointing start to the trading week this Monday. After initially rising with enthusiasm, the ASX 200 spent most of the trading session running out of steam. By market close, the...

The ASX 200 closed -0.10% in the red today, after feeling flat all day Sectors wise, Energy stocks carried the torch with enthusiasm, while Materials wasn’t let anywhere near said torch Notable performers today: pharma stock Telix (ASX:TLX...

Shares closed flattish as Aussie jobless rate falls to 3.5% Earnings season heats up as a handful of miners give updates China keeps cash rate unchanged, dashing market hopes   Local shares closed flat on Thursday as traders assessed the...

The S&P/ASX 200 Index (ASX: XJO) is on form again and on track to record a small gain. In afternoon trade, the benchmark index is up 0.2% to 7,340 points. Four ASX shares that have failed to follow the market higher today are listed...

The Telix Pharmaceuticals Ltd (ASX: TLX) share price has come under pressure on Thursday. In morning trade, the radiopharmaceutical company’s shares are down 17% to $10.06. Why is the Telix share price crashing? Investors have been selli...

World Overnight SPI Overnight 7286.00 + 2.00 0.03% S&P ASX 200 7323.70 + 39.90 0.55% S&P500 4565.72 + 10.74 0.24% Nasdaq Comp 14358.02 + 4.38 0.03% DJIA 35061.21 + 109.28 0.31% S&P500 VIX 13.76 + 0.46 3.46% US 10...

MELBOURNE, Australia, July 19, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today issues its Appendix 4C quarterly cash flow report and accompanying Activities Report for the quarter ended 30 June 2023...

MELBOURNE, Australia, July 19, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the first patient has been dosed in a Phase I study of the Company’s investigational targeted radiation...

Highlights Telix Pharmaceuticals is a radiopharmaceutical company focusing on the development of diagnostic and therapeutic radiopharmaceutical products For its Q1FY23, ended 31 March 2023, the company reported a revenue of AUD 100.1mn...

Fancy getting money without having to work for it? So do I. Believe it or not, it is possible for the average person on the street to create a handy source of passive income. In this article, I’ll explore how you can invest in ASX shares...

Telix Pharmaceuticals Limited (ASX:TLX) is a Melbourne-headquartered $3.9 billion company which recently entered the Montgomery and Australian Eagle portfolios and seems to have very exciting prospects. To backtrack, Telix’s targeted radiat...

What will the second half have in store for investors? How investors can play geopolitics and recession themes Stockhead reached out to Bell Direct’s Brady Wulff, who gave her predictions    There’s been a lot of drama in the first half o...

From box televisions to the World Wide Web, and brick phones to smartphones, artificial intelligence (AI) has been transforming the way humans process information for decades. According to Next Move Strategy Consulting, the AI market is...

In this week’s video insight David Buckland discusses two Australian biomedical companies, Pro-Medicus (ASX:PME) and Telix Pharmaceuticals (ASX:TLX) which are gaining global recognition. Pro-Medicus specialises in imaging software and has e...

The last financial year was a good one for the S&P/ASX 200 Index (ASX: XJO). The benchmark index carved out a sizeable return of 9.7% for the period. While this was strong, some ASX 200 shares delivered even stronger gains. Here’s...

It has been another busy week for Australia’s top brokers. This has led to the release of a large number of broker notes. Three broker buy ratings that you might want to know more about are summarised below. Here’s why brokers think th...

On Thursday, the S&P/ASX 200 Index (ASX: XJO) ran out of steam and edged into the red. The benchmark index fell slightly to 7,194.9 points. Will the market be able to bounce back from this on Friday? Here are five things to watch: AS...

Telix (ASX:TLX) has released further details of the positive results from its completed pivotal Phase 3 ZIRCON study of TLX250-CDx in clear cell renal cell carcinoma.

MELBOURNE, Australia, June 27, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces further details of the positive results from its completed pivotal Phase III ZIRCON study of TLX250-CDx (89Zr...

Wilsons equity strategist Rob Crookston is a happy man. Despite the turbulence in the general market, many of his team’s S&P/ASX 200 Index (ASX: XJO) holdings in the focus portfolio enjoyed earnings upgrades in recent times. Like a pro...

Avita Medical receives US FDA premarket approval for its RECELL System to treat vitiligo Telix will buy UK medical device firm Lightpoint Medical and its radio-guided surgery business SENSEI Antisense in strong position with new CEO, forme...

The Imugene Limited (ASX: IMU) share price has continued downward in the last 12 months, with the clinical-stage immuno-oncology company declining further in 2023. Unlike the reasonable 3.5% return of the S&P/ASX All Ordinaries Index...

MELBOURNE, Australia, June 22, 2023 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces presentations from the Company’s investigational prostate (prostate specific-membrane antigen, or PSMA-target...

After the S&P/ASX 200 Index (ASX: XJO) broke its near-two week winning streak yesterday, the index today sadly doubled down on those losses. The ASX 200 finished deep in red territory this Thursday. By the end of trading, the index...

MELBOURNE, Australia, June 21, 2023 /PRNewswire/ – Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business....

The S&P/ASX 200 Index (ASX: XJO) has sadly broken its near-two-week winning streak this Wednesday. After recording a gain every single session since Thursday 8 June, the ASX 200 finished up in the red today. The index closed up shop...

The ASX 200 index slumped by almost half a percent Energy stocks retreated, while Telstra, QBE, Woolworths, and IAG touched new highs Bitcoin has also hit a six-week high   The ASX slipped half a percentage point on Wednesday as traders d...